Login
| TI Ref No : | 518996372 |
|---|---|
| Description : | Contract Awarded For L01fx13 Enfortumab Vedotin the Subject Of The Public Contract Is Continuous Supplies Of Drugs Containing The Active Substance L01fx13 Enfortumab Sedotine For 4 Years. value Of The Result: winner Selection Date : 08/04/2025 date Of |
| Date : | 2025-06-10 |
| Deadline : | 2025-08-19 |
| Document Type : | Contracts |
